MedPath
NMPA Approval

Brimonidine Tartrate Eye Drops

国药准字H20253121

January 8, 2025

Drug Information

酒石酸溴莫尼定滴眼液

眼用制剂

0.2%(5ml∶10mg)

化学药品

January 8, 2025

Company Information

Applicant Company

广东省东莞市石龙镇西湖工业区信息产业园

Manufacturing Company

广东省东莞市石龙镇西湖工业区信息产业园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

酒石酸溴莫尼定滴眼液 - NMPA 批准文号 | MedPath